Here you will find all the news about PhinC Development. We keep you informed about our latest events, our publications, our partnerships and our progress in terms of R&D…

EMA gave a positive opinion about Fexinidazole

We celebrated, together with our colleagues from Drugs for Neglected Diseases initiative - DNDi and partners, the positive opinion given by the European Medicines Agency about Fexinidazole, DNDi’s first “new chemical entity”…

Read more

PhinC renews sponsorship to GMP annual symposium

PhinC Development is proud to sponsor and participate in the special event organized by the Groupe de Métabolisme et Pharmacocinétique (GMP) that will be held in Paris on 16th to 18th October 2019.

Read more

The success of our PBPK symposium 2019

PhinC Development would like to thank you for being part of this special event dedicated to the PBPK and organised jointly with Club Phase 1.

Read more
Club Phase 1
GMP - Groupe de Métabolisme et Pharmacocinétique